Product NDC: | 65862-140 |
Proprietary Name: | Cefpodoxime Proxetil |
Non Proprietary Name: | Cefpodoxime Proxetil |
Active Ingredient(s): | 50 mg/5mL & nbsp; Cefpodoxime Proxetil |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-140 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065409 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070608 |
Package NDC: | 65862-140-01 |
Package Description: | 1 BOTTLE in 1 CARTON (65862-140-01) > 100 mL in 1 BOTTLE |
NDC Code | 65862-140-01 |
Proprietary Name | Cefpodoxime Proxetil |
Package Description | 1 BOTTLE in 1 CARTON (65862-140-01) > 100 mL in 1 BOTTLE |
Product NDC | 65862-140 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefpodoxime Proxetil |
Dosage Form Name | GRANULE, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20070608 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | CEFPODOXIME PROXETIL |
Strength Number | 50 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |